Clinical Trial Update: A Study to Test How Zongertinib is Taken up in the Blood of People With and Without Liver Problems [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study assesses how Zongertinib is absorbed into the bloodstream in people with liver disease compared with healthy participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Zongertinib (Zongertinib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Liver Diseases, Healthy | Phase 1 | Status: COMPLETED